@article{ WOS:000468005700001,
Author = {Carvalho, Diana and Taylor, Kathryn R. and Olaciregui, Nagore Gene and
   Molinari, Valeria and Clarke, Matthew and Mackay, Alan and Ruddle, Ruth
   and Henley, Alan and Valenti, Melanie and Hayes, Angela and Brandon,
   Alexis De Haven and Eccles, Suzanne A. and Raynaud, Florence and
   Boudhar, Aicha and Monje, Michelle and Popov, Sergey and Moore, Andrew
   S. and Mora, Jaume and Cruz, Ofelia and Vinci, Mara and Brennan, Paul E.
   and Bullock, Alex N. and Carcaboso, Angel Montero and Jones, Chris},
Title = {ALK2 inhibitors display beneficial effects in preclinical models of
   ACVR1 mutant diffuse intrinsic pontine glioma},
Journal = {COMMUNICATIONS BIOLOGY},
Year = {2019},
Volume = {2},
Month = {MAY 9},
DOI = {10.1038/s42003-019-0420-8},
Article-Number = {156},
EISSN = {2399-3642},
ResearcherID-Numbers = {Jones, Chris/ABE-6059-2021
   Moore, Andrew/I-6275-2012
   Ruddle, Ruth/MTD-4041-2025
   Maio, Michele/AEV-2647-2022
   cruz, ofelia/AAE-7058-2020
   Vinci, Maria/AAI-1092-2019
   },
ORCID-Numbers = {Raynaud, Florence/0000-0003-0957-6279
   Carvalho, Diana/0000-0001-6881-6151
   Carcaboso, Angel/0000-0002-8485-426X
   Vinci, Maria/0000-0002-7952-6771
   Brennan, Paul/0000-0002-8950-7646
   cruz, ofelia/0000-0001-7102-3283
   Moore, Andrew/0000-0001-8062-1779},
Unique-ID = {WOS:000468005700001},
}

{"_id":"xzjMMzkSd5TRJ3S3v","bibbaseid":"carvalho-taylor-olaciregui-molinari-clarke-mackay-ruddle-henley-etal-alk2inhibitorsdisplaybeneficialeffectsinpreclinicalmodelsofacvr1mutantdiffuseintrinsicpontineglioma-2019","author_short":["Carvalho, D.","Taylor, K. R.","Olaciregui, N. G.","Molinari, V.","Clarke, M.","Mackay, A.","Ruddle, R.","Henley, A.","Valenti, M.","Hayes, A.","Brandon, A. D. H.","Eccles, S. A.","Raynaud, F.","Boudhar, A.","Monje, M.","Popov, S.","Moore, A. S.","Mora, J.","Cruz, O.","Vinci, M.","Brennan, P. E.","Bullock, A. N.","Carcaboso, A. M.","Jones, C."],"bibdata":{"bibtype":"article","type":"article","author":[{"propositions":[],"lastnames":["Carvalho"],"firstnames":["Diana"],"suffixes":[]},{"propositions":[],"lastnames":["Taylor"],"firstnames":["Kathryn","R."],"suffixes":[]},{"propositions":[],"lastnames":["Olaciregui"],"firstnames":["Nagore","Gene"],"suffixes":[]},{"propositions":[],"lastnames":["Molinari"],"firstnames":["Valeria"],"suffixes":[]},{"propositions":[],"lastnames":["Clarke"],"firstnames":["Matthew"],"suffixes":[]},{"propositions":[],"lastnames":["Mackay"],"firstnames":["Alan"],"suffixes":[]},{"propositions":[],"lastnames":["Ruddle"],"firstnames":["Ruth"],"suffixes":[]},{"propositions":[],"lastnames":["Henley"],"firstnames":["Alan"],"suffixes":[]},{"propositions":[],"lastnames":["Valenti"],"firstnames":["Melanie"],"suffixes":[]},{"propositions":[],"lastnames":["Hayes"],"firstnames":["Angela"],"suffixes":[]},{"propositions":[],"lastnames":["Brandon"],"firstnames":["Alexis","De","Haven"],"suffixes":[]},{"propositions":[],"lastnames":["Eccles"],"firstnames":["Suzanne","A."],"suffixes":[]},{"propositions":[],"lastnames":["Raynaud"],"firstnames":["Florence"],"suffixes":[]},{"propositions":[],"lastnames":["Boudhar"],"firstnames":["Aicha"],"suffixes":[]},{"propositions":[],"lastnames":["Monje"],"firstnames":["Michelle"],"suffixes":[]},{"propositions":[],"lastnames":["Popov"],"firstnames":["Sergey"],"suffixes":[]},{"propositions":[],"lastnames":["Moore"],"firstnames":["Andrew","S."],"suffixes":[]},{"propositions":[],"lastnames":["Mora"],"firstnames":["Jaume"],"suffixes":[]},{"propositions":[],"lastnames":["Cruz"],"firstnames":["Ofelia"],"suffixes":[]},{"propositions":[],"lastnames":["Vinci"],"firstnames":["Mara"],"suffixes":[]},{"propositions":[],"lastnames":["Brennan"],"firstnames":["Paul","E."],"suffixes":[]},{"propositions":[],"lastnames":["Bullock"],"firstnames":["Alex","N."],"suffixes":[]},{"propositions":[],"lastnames":["Carcaboso"],"firstnames":["Angel","Montero"],"suffixes":[]},{"propositions":[],"lastnames":["Jones"],"firstnames":["Chris"],"suffixes":[]}],"title":"ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma","journal":"COMMUNICATIONS BIOLOGY","year":"2019","volume":"2","month":"MAY 9","doi":"10.1038/s42003-019-0420-8","article-number":"156","eissn":"2399-3642","researcherid-numbers":"Jones, Chris/ABE-6059-2021 Moore, Andrew/I-6275-2012 Ruddle, Ruth/MTD-4041-2025 Maio, Michele/AEV-2647-2022 cruz, ofelia/AAE-7058-2020 Vinci, Maria/AAI-1092-2019 ","orcid-numbers":"Raynaud, Florence/0000-0003-0957-6279 Carvalho, Diana/0000-0001-6881-6151 Carcaboso, Angel/0000-0002-8485-426X Vinci, Maria/0000-0002-7952-6771 Brennan, Paul/0000-0002-8950-7646 cruz, ofelia/0000-0001-7102-3283 Moore, Andrew/0000-0001-8062-1779","unique-id":"WOS:000468005700001","bibtex":"@article{ WOS:000468005700001,\nAuthor = {Carvalho, Diana and Taylor, Kathryn R. and Olaciregui, Nagore Gene and\n Molinari, Valeria and Clarke, Matthew and Mackay, Alan and Ruddle, Ruth\n and Henley, Alan and Valenti, Melanie and Hayes, Angela and Brandon,\n Alexis De Haven and Eccles, Suzanne A. and Raynaud, Florence and\n Boudhar, Aicha and Monje, Michelle and Popov, Sergey and Moore, Andrew\n S. and Mora, Jaume and Cruz, Ofelia and Vinci, Mara and Brennan, Paul E.\n and Bullock, Alex N. and Carcaboso, Angel Montero and Jones, Chris},\nTitle = {ALK2 inhibitors display beneficial effects in preclinical models of\n ACVR1 mutant diffuse intrinsic pontine glioma},\nJournal = {COMMUNICATIONS BIOLOGY},\nYear = {2019},\nVolume = {2},\nMonth = {MAY 9},\nDOI = {10.1038/s42003-019-0420-8},\nArticle-Number = {156},\nEISSN = {2399-3642},\nResearcherID-Numbers = {Jones, Chris/ABE-6059-2021\n Moore, Andrew/I-6275-2012\n Ruddle, Ruth/MTD-4041-2025\n Maio, Michele/AEV-2647-2022\n cruz, ofelia/AAE-7058-2020\n Vinci, Maria/AAI-1092-2019\n },\nORCID-Numbers = {Raynaud, Florence/0000-0003-0957-6279\n Carvalho, Diana/0000-0001-6881-6151\n Carcaboso, Angel/0000-0002-8485-426X\n Vinci, Maria/0000-0002-7952-6771\n Brennan, Paul/0000-0002-8950-7646\n cruz, ofelia/0000-0001-7102-3283\n Moore, Andrew/0000-0001-8062-1779},\nUnique-ID = {WOS:000468005700001},\n}\n\n","author_short":["Carvalho, D.","Taylor, K. R.","Olaciregui, N. G.","Molinari, V.","Clarke, M.","Mackay, A.","Ruddle, R.","Henley, A.","Valenti, M.","Hayes, A.","Brandon, A. D. H.","Eccles, S. A.","Raynaud, F.","Boudhar, A.","Monje, M.","Popov, S.","Moore, A. S.","Mora, J.","Cruz, O.","Vinci, M.","Brennan, P. E.","Bullock, A. N.","Carcaboso, A. M.","Jones, C."],"key":"WOS:000468005700001","id":"WOS:000468005700001","bibbaseid":"carvalho-taylor-olaciregui-molinari-clarke-mackay-ruddle-henley-etal-alk2inhibitorsdisplaybeneficialeffectsinpreclinicalmodelsofacvr1mutantdiffuseintrinsicpontineglioma-2019","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/network/files/HECPruWhe6gDg5ZWN","dataSources":["qhzgQBKWKwmm6xY73","NBNKNR2KcNSWDgFcf","2252seNhipfTmjEBQ","4mccB2G6uYe3AhfDs"],"keywords":[],"search_terms":["alk2","inhibitors","display","beneficial","effects","preclinical","models","acvr1","mutant","diffuse","intrinsic","pontine","glioma","carvalho","taylor","olaciregui","molinari","clarke","mackay","ruddle","henley","valenti","hayes","brandon","eccles","raynaud","boudhar","monje","popov","moore","mora","cruz","vinci","brennan","bullock","carcaboso","jones"],"title":"ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma","year":2019}